On April 28, 2025, 180 Life Sciences Corp. reached a $1 million Settlement Agreement to acquire 1,318,000 shares from Elray, with payments structured over time. The agreement addressed disputes related to previous potential acquisitions, and included a Voting Agreement for future shareholder decisions.